Tempo Australia Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tempo Australia Limited with three other
companies in this sector in Australia:
sales of 58.52 million Australian Dollars [US$43.77 million]
of which 100%
was Mesenchymal Precursor Cell),
(18.57 million Australian Dollars [US$13.89 million]
of which 80%
was Bronchitol and Aridol), and
Xrf Scientific Ltd
(21.13 million Australian Dollars [US$15.81 million]
of which 43%
was Precious Metals).
During the year ended December of 2016, sales at
Tempo Australia Limited were A$81.37 million (US$60.86 million).
increase of 2.8%
versus 2015, when the company's sales were A$79.15 million.
This was the fifth consecutive year of sales increases at Tempo Australia Limited
(and since 2011, sales have increased a total of 390,671%).